EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo. (Q51394956)
Jump to navigation
Jump to search
scientific article published on 13 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo. |
scientific article published on 13 October 2016 |
Statements
1 reference
EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo. (English)
1 reference
Chenfei Zhou
1 reference
Liangjun Zhu
1 reference
Jun Ji
1 reference
Fangmi Ding
1 reference
Chao Wang
1 reference
Qu Cai
1 reference
Yingyan Yu
1 reference
Zhenggang Zhu
1 reference
Jun Zhang
1 reference
13 October 2016
1 reference
17
1 reference
1
1 reference
89-97
1 reference
Identifiers
1 reference